Package 0904-7465-61

Brand: bupropion hydrochloride sr

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0904-7465-61
Digits Only 0904746561
Product NDC 0904-7465
Description

100 BLISTER PACK in 1 CARTON (0904-7465-61) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

Marketing

Marketing Status
Marketed Since 2024-11-15
Brand bupropion hydrochloride sr
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "bc353d98-bf85-4efb-995a-bb3dfd28825c", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993518"], "spl_set_id": ["67b6bcf8-0e7c-4e74-ad72-54f1bd6e65ad"], "manufacturer_name": ["Major Pharmaceuticals"]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (0904-7465-61)  / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "0904-7465-61", "marketing_start_date": "20241115"}], "brand_name": "bupropion hydrochloride SR", "product_id": "0904-7465_bc353d98-bf85-4efb-995a-bb3dfd28825c", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0904-7465", "generic_name": "bupropion hydrochloride", "labeler_name": "Major Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA202304", "marketing_category": "ANDA", "marketing_start_date": "20241115", "listing_expiration_date": "20271231"}